Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-042029·PSYENCE BIOMEDICAL LTD.
Schedule 13D ownership disclosure
PSYENCE BIOMEDICAL LTD
Common Shares, without par value · CUSIP: 74449F308
Event date: 2025-05-02
- Filing-level shares
- 0.00
- Percent of class
- 0%
- Psyence Group Inc.Reported CIK 0002009573
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-042029
- Form type
- SCHEDULE 13D/A
- Filer
- PSYENCE BIOMEDICAL LTD.
- CIK
- CIK 1985062
- Filed
- May 12, 2025
- Reporting period
- May 02, 2025
- Description
- Schedule 13D beneficial ownership